Instil Bio, Inc. — Income Charts
2 years of history · ending 2021-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
R&D
$107M
D&A
$3M
Operating Income
$-156M
EBITDA
$-153M
Interest Expense
$0
Other Income/Expense
$-1M
Pretax Income
$-157M
Tax Provision
$39K
Net Income
$-157M
Operating Margin
-24379.7%
Net Margin
-27346.4%
Effective Tax Rate
-0.0%
Deferred Tax Assets
$3M
Deferred Tax Liabilities
$2M
DTA Valuation Allowance
$43M
Tax Credit Carryforwards
$5M
NOL Carryforwards
$37M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
—
ETR Foreign Differential (pp)
—
Operating Lease Cost
$3M
Revenue YoY Variation
-100.0%
Income YoY Variation
-362.4%